Polaryx Therapeutics Highlights Participation in NCL Scientific Conference and NTSAD Imagine & Believe Event
Scientific presentation and patient advocacy engagement follow activation of the first clinical trial site for SOTERIA Scientific presentation and patient advocacy engagement follow activation of the first clinical trial site for SOTERIA